Clinical Genomics Appoints Mark Boyle President, In Vitro Diagnostics
21 déc. 2016 10h12 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
Clinical Genomics Appoints Mark Boyle President, In Vitro Diagnostics
21 déc. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
Clinical Genomics Announces the Launch of Colvera™ for Colorectal Cancer Recurrence Monitoring
20 déc. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera™, a...
Clinical Genomics Announces Appointment of Michael Dugan, M.D. as Chief Medical Officer
14 nov. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-driven diagnostic tools for colorectal cancer, today announced the appointment of...
Clinical Genomics Strengthens its Leadership Team with Multiple Key Appointments
13 oct. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative healthcare solutions for cancer diagnosis, today announced the appointments of Laurie...
Data Published in Cancer Medicine Demonstrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test
12 oct. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its...
Clinical Genomics Celebrates Ten Years of Innovation
29 sept. 2016 08h00 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, marks a decade of discovery and innovation as...
Clinical Genomics Announces Implementation of UNIConnect® Precision Molecular Diagnostics Laboratory Information Management System
02 juin 2016 07h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J. and SALT LAKE CITY, June 02, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing advanced diagnostic tools for colorectal cancer, today announced that it has...
Clinical Genomics Announces Closing of $15 Million Series A Financing Round
23 mars 2016 07h00 HE
|
Clinical Genomics
Investment will support commercialization of company’s blood-based test for colorectal cancer recurrence Appoints Dr. Paul Kelly to board of directors EDISON, N.J., March 23, 2016 (GLOBE...
Clinical Genomics Presents Data Supporting Novel 2-Gene Blood Test for Earlier Detection of Colorectal Cancer Recurrence at ASCO GI
25 janv. 2016 08h00 HE
|
Clinical Genomics
EDISON, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing next-generation diagnostic tools for colorectal cancer, today announced new data supporting its 2-gene...